Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. (Q46132987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

chronic myeloid leukemia

0 references

1 reference

1 reference

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Y Luo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

X-Y Lai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Y-M Tan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J-M Shi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Y-M Zhao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

X-Y Han

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

G-F Zheng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

X-L Zhu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J Sun

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Y-L Zheng

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

G-Q Wu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J-S He

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S-Y Chen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A-Y Jin

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

W-Z Xie

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

X-J Ye

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Z Cai

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

M-F Lin

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

5 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1171-1174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19194468%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.401

20 January 2020

exact match

0 references

cites work

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.401

7 January 2021

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.401

7 January 2021

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.401

7 January 2021

Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.401

7 January 2021

Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.401

7 January 2021